Particle Data Platform

50 Hour, 600 MCQ USMLE Step 2/3 Review (12/1-10, 2026)

6/24/20265 min

In this podcast, I discuss the 50 hr class (5.45-10.45 pm EST each day via zoom from December 1-10, 2026) that provides a remarkably comprehensive review for the USMLE Step 2/3 (or COMLEX Level 2/3) exams. The class in an integrated fashion, thoroughly examines content, pathophysiology, testing principles, how the NBMEs create right and wrong … Continue reading 50 Hour, 600 MCQ USMLE Step 2/3 Review (12/1-10, 2026)

Transcript preview

First 90 seconds
  1. Divine· Host0:00

    All right. Uh, welcome. My name is Divine. Uh, this is a discussion of the fifty-hour, six hundred multiple-choice question class. Um, this class is a one-of-a-kind class, and it's gonna be taking place, um, between the first and the tenth of December this year. Um, you know, at first I could only host this in June, but, uh, had a window of opportunity with my schedule, so I'm gonna be hosting this again in December. But basically, what's the deal with this class? This class, it's a one-of-a-kind class that really is intended to provide just phenomenal, phenomenal, phenomenal present-- uh, preparation for the USMLE Step Two CK, Step Three exams and the, you know, level two and level three exams. And what are the key highlights of this class? Well, very comprehensive coverage. Very, very comprehensive coverage of the content areas, you know, across internal medicine, pedes, psych, neurology, surgery, and OBGYN. And one thing that is unique about this course is that the coverage is done by way of multiple-choice questions, right? I use multiple-choice questions to emphasize the concepts and to emphasize very important test-taking strategies. Very, very important test-taking strategies. You know, basically as you're wading through each question, you're just getting a very solid grounding in the way the NBME's go about testing material, both from a content perspective and from a knowledge and recog-- and from a, you know, recognition and test-taking perspective,

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.